From: Robust edge-based biomarker discovery improves prediction of breast cancer metastasis
GO term | Gene | CEEdge | PPIEdge |
---|---|---|---|
Cell cycle | 2.3E-15 | 4.5E-19 | 2.0E-30 |
Sister chromatid cohesion | 4.4E-5 | 1.7E-5 | 5.1E-12 |
Anaphase-promoting complex-dependent catabolic process | 4.4E-5 | 8.8E-6 | 1.4E-7 |
Negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.9E-4 | 3.2E-4 | 1.1E-5 |
Antigen processing and presentation of exogenous peptide antigen via MHC class II | 7.1E-4 | 3.8E-2 | 2.9E-3 |
DNA repair | 4.2E-1 | 3.8E-1 | 8.8E-3 |
Positive regulation of telomere maintenance via telomerase | 3.6E-1 | Â | 1.4E-2 |
Cell-cell adhesion | Â | Â | 1.7E-2 |
T cell receptor signaling pathway | 6.0E-1 | 9.7E-1 | 6.7E-2 |
p53 signaling pathway | 4.9E-2 | 1.1E-1 | 6.4E-2 |
RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage | 7.6E-1 | 9.0E-1 | 1.2E-1 |
Wnt signaling pathway, planar cell polarity pathway | 8.1E-1 | 5.3E-1 | 2.1E-1 |
Natural killer cell mediated cytotoxicity | 9.5E-1 | Â | 8.8E-1 |
Focal adhesion | Â | Â | 9.7E-1 |
Small cell lung cancer | 7.0E-1 | 6.3E-1 | 3.8E-2 |
Jak-STAT signaling pathway | 9.7E-1 | 9.9E-1 | 9.5E-1 |
Tumor necrosis factor-mediated signaling pathway | 6.5E-1 | 5.9E-1 | 2.1E-2 |